NYSE American - Delayed Quote USD
Lineage Cell Therapeutics, Inc. (LCTX)
Tune into live earnings calls Now streaming directly on quote pages.
0.4400
-0.0300
(-6.38%)
At close: May 9 at 4:00:00 PM EDT
0.4381
-0.00
(-0.43%)
After hours: May 9 at 6:22:52 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-23,092
-23,092
-28,566
1,059
-23,561
Investing Cash Flow
-2,308
-2,308
46,449
-46,159
9,745
Financing Cash Flow
35,857
35,857
6,423
1,632
36,930
End Cash Position
46,354
46,354
35,992
11,936
56,277
Interest Paid Supplemental Data
9
9
10
13
13
Capital Expenditure
-565
-565
-674
-413
-340
Issuance of Capital Stock
35,876
35,876
6,426
148
30,865
Issuance of Debt
--
--
--
--
0
Repayment of Debt
-54
-54
-54
-32
-20
Repurchase of Capital Stock
-23
-23
-37
-17
-54
Free Cash Flow
-23,657
-23,657
-29,240
646
-23,901
12/31/2021 - 3/5/1992
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GERN Geron Corporation
1.1800
-6.35%
VCEL Vericel Corporation
41.73
-0.33%
FATE Fate Therapeutics, Inc.
1.0400
+0.97%
SER Serina Therapeutics, Inc.
5.63
-2.01%
NKGN NKGen Biotech, Inc.
0.1711
+3.70%
CLDX Celldex Therapeutics, Inc.
18.33
-6.10%
PCSA Processa Pharmaceuticals, Inc.
0.2390
-12.77%
BLRX BioLineRx Ltd.
3.1700
-0.94%
LPTX Leap Therapeutics, Inc.
0.3350
-7.23%
CGEN Compugen Ltd.
1.2600
-2.33%